Loading
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Latest filing published 15 Apr 2026 for Knight Therapeutics Inc., €2,691.
Filing timeline
BuySaleJames Gale
Insider track record
Disclosed buys
2
Disclosed sells
0
Signal history
James Gale: trading record in brief
All filings by James Gale on record concern Knight Therapeutics Inc. The record holds 4 filings, for trades running from 14 January 2021 to 13 April 2026.
Every open-market trade on record is a purchase: 2 purchases worth €17k, and no sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 2 option exercises.
The latest filing, published on 15 April 2026, reports an option exercise of €2,691 in Knight Therapeutics Inc. The most recent open-market purchase was published on 14 January 2021, 2,111 days ago. Filings reach the SEDI feed a median of 1 day after the trade. This delay matters because a trade only becomes useful information once it is public. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
Companies and markets linked to James Gale
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations4 total
591 shares@ CA$7.3910.8% of flowCommon SharesTSXSEDI:4704855
1,353 shares@ CA$5.6523.2% of flowCommon SharesTSXSEDI:4316927
500 shares@ CA$5.3010.1% of flowCommon SharesTSXSEDI:3663006
Canonical exit: 14 Apr 2021 (T+90)
4,500 shares@ CA$5.2789.9% of flowCommon SharesTSXSEDI:3663004
Canonical exit: 14 Apr 2021 (T+90)
4 of 4 declarations
